• PDF / 186,191 Bytes
• 1 Pages / 595.245 x 841.846 pts (A4) Page_size
• 65 Downloads / 156 Views

DOWNLOAD

REPORT

-5503/20/0860-0001/$14.95 Adis © 2020 Springer Nature Switzerland AG. All rights reserved

PharmacoEconomics & Outcomes News 22 Aug 2020 No. 860

1

Recommend Documents

Adding polatuzumab vedotin cost effective in large B-cell lymphoma

152 35 163KB

Cost-Effective

168 109 57MB

Atorvastatin cost effective in T2DM

163 57 182KB

Atomoxetine cost-effective in ADHD

158 88 139KB

Highly Cost-Effective Intervention

195 83 57MB

Indian System

163 0 700KB

Synflorix cost effective versus PCV13 in Taiwan

208 39 182KB

Trastuzumab cost effective in early breast cancer

115 43 122KB

Double CBT cost effective in acute leukaemia

157 46 115KB

Bevacizumab + capecitabine not cost effective in mCRC

162 48 111KB

Semaglutide cost effective versus dulaglutide in Japan

170 20 182KB

Preoperative lymphoscintigraphy cost effective in vulvar cancer

157 31 166KB